Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

Personal Finance

AbbVie : ABBV

All AbbVie Articles

601 Articles

Drew Wood | Jun 13, 2026 at 8:02 AM EDT

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Paying $2,000 a month in rent is often described as throwing money away. Homeownership, by contrast, is treated as the…

David Beren | Jun 12, 2026 at 7:23 AM EDT

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

If you own JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), you bought it for a reason that still holds. JEPI pays monthly. It…

Alex Sirois | Jun 11, 2026 at 2:22 PM EDT

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

AbbVie (NYSE:ABBV | ABBV Price Prediction) at $224.95 sits at the center of a sharp bull-bear debate. The pharma giant…

Joel South | Jun 10, 2026 at 4:05 PM EDT

3 Dividend Stocks Built for Retirement to Buy in June

Mid-year is when income-focused investors tend to take a hard look at their portfolios. With the second half of 2026…

Drew Wood | Jun 8, 2026 at 1:34 PM EDT

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

A retiree’s $40,000 dividend income stream sounds modest next to a neighbor’s $90,000. But the growth rate often matters more…

Alex Sirois | Jun 7, 2026 at 10:13 AM EDT

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

Bristol Myers Squibb (NYSE:BMY | BMY Price Prediction) is the headline pharma name dividend hunters keep circling, drawn in by…

David Beren | Jun 6, 2026 at 12:11 PM EDT

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

A 63-year-old retiree with $400,000 parked in the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) likely picked it for the 100-stock…

Alex Sirois | Jun 3, 2026 at 12:06 PM EDT

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

Ten years ago, AbbVie (NYSE:ABBV | ABBV Price Prediction) was a one-drug story. Humira, the world’s best-selling medicine, threw off…

Joel South | Jun 3, 2026 at 7:45 AM EDT

This Is What a $1 Million Dividend Portfolio Pays After Taxes

At the 24% federal bracket, a $1 million dividend portfolio generating roughly $45,000 in annual income can hand the IRS…

John Seetoo | May 29, 2026 at 10:01 AM EDT

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

The Vanguard High Dividend Yield Index Fund ETF Shares (NYSEARCA:VYM) is one of the simplest income vehicles in the market:…

John Seetoo | May 28, 2026 at 11:44 AM EDT

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has become one of the most-owned dividend funds in the country, with $71.6 billion…

Omor Ibne Ehsan | May 26, 2026 at 9:50 AM EDT

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Most investors buy Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) because the fund’s reputation tells them they are buying diversification. SCHD…

Vandita Jadeja | May 25, 2026 at 7:47 AM EDT

Two Paths to Growth: Johnson & Johnson vs AbbVie

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and AbbVie (NYSE:ABBV) both posted Q1 2026 results that beat revenue expectations…

Joel South | May 23, 2026 at 8:41 AM EDT

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

Holding a high-yield dividend portfolio in a taxable account at the 24% federal bracket means writing the IRS a $14,400…

Joel South | May 22, 2026 at 7:36 AM EDT

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Replacing a real paycheck with dividends is the cleanest version of financial independence. The income target here is $65,000 per…

1 2 3 4 … 41

AbbVie : ABBV

All AbbVie Articles

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

This Is What a $1 Million Dividend Portfolio Pays After Taxes

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Two Paths to Growth: Johnson & Johnson vs AbbVie

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

RFK Jr. Recommends Immediately Hiking Taxes as Much as $7,841 to Close Social Security’s “Unfunded Obligation” Gap

Is XRP a Better Investment Than Bitcoin Right Now?

Arm Holdings vs Advanced Micro Devices: One Winner of The AI Data Center Showdown

RFK Jr. Recommends Immediately Hiking Taxes as Much as $7,841 to Close Social Security's "Unfunded Obligation" Gap

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.

RFK Jr. Recommends Immediately Hiking Taxes as Much as $7,841 to Close Social Security’s “Unfunded Obligation” Gap

Is XRP a Better Investment Than Bitcoin Right Now?

AbbVie : ABBV

All AbbVie Articles

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

This Is What a $1 Million Dividend Portfolio Pays After Taxes

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Two Paths to Growth: Johnson & Johnson vs AbbVie

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

RFK Jr. Recommends Immediately Hiking Taxes as Much as $7,841 to Close Social Security’s “Unfunded Obligation” Gap

Is XRP a Better Investment Than Bitcoin Right Now?

Arm Holdings vs Advanced Micro Devices: One Winner of The AI Data Center Showdown

Featured Reads

RFK Jr. Recommends Immediately Hiking Taxes as Much as $7,841 to Close Social Security's "Unfunded Obligation" Gap

Only 30% of Americans Ever Receive an Inheritance. Those Who Do Get It at 58, Not 30.